Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Postpartum Aortic Dissection Without Aortic Dilation in a Woman With an ACTA2 Gene Mutation.

JACC. Case reports·2026
Same author

Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Defecation Patterns and Cardiovascular Outcomes in Acute Coronary Syndrome: The Influence of Stimulant Laxative Use.

JACC. Asia·2026
Same author

Right Atrial Function as a Novel Predictor for New-Onset Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy.

Journal of the American Heart Association·2026
Same author

Epidemiological and clinical evidence on blood pressure management for the prevention of dementia: striving for a healthy 100-year life.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

High Human Epididymis Protein 4 Levels Are Associated With Lower Systolic Function and Poor Prognosis in Heart Failure With Reduced Ejection Fraction.

Circulation journal : official journal of the Japanese Circulation Society·2026

相关实验视频

Updated: Jan 10, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.2K

用高灵敏度凝血试验对心血管疾病的初始血栓生成进行分析.

Akira Fujiyama1,2, Yuichiro Arima1,3,4, Rina Inoue5

  • 1Developmental Cardiology Laboratory, International Research Center for Medical Science (IRCMS), Kumamoto University, Kumamoto, Japan.

Thrombosis and haemostasis
|November 21, 2025
PubMed
概括

初始血栓生成 (ITG) 测量显示,对监测抗凝剂治疗有希望. 不同的ITG通路受到直接口服抗凝剂和各种疾病的影响,为凝血潜力提供了洞察力.

更多相关视频

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.2K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.3K

相关实验视频

Last Updated: Jan 10, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.2K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.2K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.3K

科学领域:

  • 凝血科学是一门凝血科学.
  • 发现生物标志物的发现.
  • 血栓形成的研究研究

背景情况:

  • 初始血栓生成 (ITG) 对于血液凝固至关重要,由组织因子 (TF) 驱动和FVIIIa/FIXa依赖的途径启动.
  • 作为血栓发生率标志物或用于监测口服抗FXa治疗的ITG的临床实用性尚未得到充分证实.

研究的目的:

  • 通过TF驱动和FVIIIa/FIXa依赖的途径评估测量ITG的临床实用性.
  • 评估直接口服抗凝剂 (DOAC) 和临床条件对ITG的影响.
  • 为了确定ITG是否可以作为抗凝剂疗效的生物标志物.

主要方法:

  • 在健康成年人和771名心血管疾病患者的血中测量了ITG.
  • 分析包括服用DOACs的患者和不服用抗凝药的患者.
  • 使用接收器操作特征 (ROC) 分析和后勤回归来评估ITG路径.

主要成果:

  • 在TF驱动的和FVIIIa/FIXa依赖的途径中,DOAC治疗显著抑制了血栓生成.
  • ROC分析显示,在检测DOAC使用时,这两种途径都有很高的区分能力.
  • 透析,慢性病和活跃癌症与改变的ITG有关,对TF驱动的途径有特定的影响.

结论:

  • 来自TF-和FVIIIa/FIXa依赖途径的ITG潜力是评估抗凝剂疗效的有希望的生物标志物.
  • 不同的病理状况不同影响凝血路径,需要在ITG评估中考虑疾病背景.